
|Articles|September 1, 2001
The American Journal of Managed Care
- September 2001
- Volume 7
- Issue 9
A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
3
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
4
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
5














































